Los Angeles Capital Management
CRDF icon

Los Angeles Capital Management’s Cardiff Oncology CRDF Stock Holding History

Los Angeles Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,655
Closed -$77.7K – 1390
2025
Q2 		$77.7K Buy
+24,655
New +$75.2K ﹤0.01% 1271

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Los Angeles Capital Management's CRDF Position: Q3 2025 in Review

Los Angeles Capital Management sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 24,655 shares — an estimated $77.7K sold.

Los Angeles Capital Management first reported a position in CRDF in Q2 2025 and held it in 1 quarter. The position peaked at $77.7K in Q2 2025. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.

  • Los Angeles Capital Management reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 24,655 Cardiff Oncology shares in Q3 2025, an estimated $77.7K.
  • Los Angeles Capital Management first reported a position in Cardiff Oncology in Q2 2025 and held it in 1 quarter.
  • Los Angeles Capital Management's Cardiff Oncology position peaked at $77.7K in Q2 2025.
  • 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.

Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.